Stay updated on Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in NSCLC Clinical Trial page.
Latest updates to the Immunotherapy in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision history updated from v3.2.0 to v3.3.2 on the page. Other content appears unchanged.SummaryDifference0.0%
- Check28 days agoChange DetectedRemoval of the government funding status notice from the study page; it does not alter the study details, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check35 days agoChange DetectedThe Taiwan site location was updated from 'Tainan City, Taiwan' to 'Tainan, Taiwan'.SummaryDifference0.1%
- Check42 days agoChange DetectedThe core study details remain unchanged (no modifications to trial arms, eligibility criteria, outcomes, or listed locations); only minor formatting adjustments and timestamp metadata updates were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check71 days agoChange Detected- Added a government funding notice and operating status details (affecting core content and important time-sensitive information). - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%
- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in NSCLC Clinical Trial page.